A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels "TNT"


Phase 4 Results

Eligibility Criteria

Inclusion Criteria

Men and women age 35-75 who have evident CHD

Exclusion Criteria

Known hypersensitivity to HMG CO-A reductase therapy, liver disease, evidence of secondary hyperlipidemia